NRI.TO - Nuvo Pharmaceuticals Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue17,52327,03920,49513,057
Cost of Revenue8,68612,77411,03613,588
Gross Profit8,83714,2659,459-531
Operating Expenses
Research Development----
Selling General and Administrative7,0516,6772,64512,978
Non Recurring----
Total Operating Expenses15,73719,45113,68126,566
Operating Income or Loss1,7867,5886,814-13,509
Income from Continuing Operations
Total Other Income/Expenses Net-204-1791,52152,118
Earnings Before Interest and Taxes1,7867,5886,814-13,509
Interest Expense----713
Income Before Tax1,5827,4098,33538,609
Income Tax Expense1-719
Minority Interest----
Net Income From Continuing Ops1,5817,4098,32838,590
Non-recurring Events
Discontinued Operations--3,180-15,448-15,448
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income1,5814,229-7,12038,590
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares1,5814,229-7,12038,590